Encarnación Cruz y el futuro RD de Precios
EL GLOBAL
Mis sinceras felicitaciones a la nueva directora general de Cartera Básica del SNS y Farmacia, Encarnación Cruz, y también mis mejores deseos de éxitos en su gestión. Tal y como se ha recogido en diversos medios, es evidente que uno de los temas candentes en su agenda será la aprobación del nuevo Real Decreto de... Read More
Faus & Moliner participates in the International Conference on risks associated with the consumption of medicinal products and foods
Eduard Rodellar makes a presentation on the challenges which innovation and research are facing in the field of biomedicine
The conference, held on 11 and 12 May, has been organized by the Faculty of Law of the University of Granada, and the participants were mainly university professors and representatives of the different Public Administrations. From the ethical-legal perspective of the risks associated with the consumption of medicinal products and foods, many issues of interest... Read More
Medicinal products in the European Union in 2020
With regard to the Resolution of the European Parliament, of 2 March 2017, and the Conclusions of the European Council of 17 June 2016
CAPSULAS Nº 181
Background The Resolution approved by the European Parliament on 2 March 2017 concerning the EU options to improve access to medicines is a politically-charged document, produced as a result of the Cabezón Report promoted by the Spanish Socialist Member of the European Parliament, Soledad Cabezón. Therefore, it is not surprising that many regard it as... Read More
Possibility of applying for a review of preparatory acts prior to contracts being awarded
Judgment of the Court of Justice of the European Union (CJEU) of 5 April 2017 (Case C-391/15), Marina del Mediterráneo S.L. and others
CAPSULAS Nº 181
Background This judgment has its origin in the action brought by Marina del Mediterráneo S.L. and other companies against a decision taken by the contracting authority allowing a tenderer to participate in the public procurement procedure. The action was dismissed and Marina del Mediterráneo, S.L. and others applied for a review of the decision before... Read More
New online system to report anti-competitive practices before the CNMC and the European Commission
Mailboxes for cooperation with the Competition authorities
CAPSULAS Nº 181
In March, both the European Commission (16 March) and the Spanish Markets and Competition Commission (31 March) have published on their websites details on the implementation of new tools to detect collusive agreements and other anti-competitive practices. Using these systems, any citizen or company can provide information anonymously in order to help detect anti-competitive practices.... Read More
Faus & Moliner participates at the conference “The role of generics after 20 years in Spain” organized by DiarioFarma
Juan Suárez participated in the round table on "Policies and legislative trends outside Spain"
The conference organized by DiarioFarma was held on Monday 24 of April 2017 in Madrid.
Esto del derecho farmacéutico…
EL GLOBAL
Disculpen, pero hoy toca un poco de autobombo y alguna reflexión al hilo del mismo. La semana pasada, nos endulzaron las vacaciones anunciando que la Guía Chambers & Partners, una publicación de prestigio que evalúa de forma independiente la reputación de miles de abogados en Europa, había vuelto a designar a Faus & Moliner como... Read More
Faus & Moliner, leader in pharmaceutical law in Spain
Jordi Faus, the best lawyer for pharmaceutical law in Spain according to the Chambers & Partners Guide 2017
This year, once more, Faus & Moliner has been considered the leading firm in the area of pharmaceutical law in Spain by the Chambers & Partners Guide, a prestigious publication that assesses independently the reputation and competence of thousands of lawyers in Europe. Those consulted by the Chambers & Partners team have praised the degree... Read More
Las restricciones de derechos en virtud del principio de salud pública no pueden justificarse de forma genérica
A propósito de la sentencia del Tribunal de Justicia de la Unión Europea de 19 de octubre de 2016, Asunto C-148/15, “Deutsche Parkinson”
Cuadernos de Derecho Farmacéutico, Núm. 60, Enero-Marzo 2017
The judgement of the European Court of Justice that we comment in this article allows to request a higher degree of rigour to those who intend to support their position invoking the principle of protection of public health. In this article we analyze Spanish and EU case-law that have modelled the principle of protection of... Read More
Mejorar el acceso, una cuestión multidisciplinar
El Global
Para los que no consiguen desconectar del todo durante estas mini-vacaciones de Semana Santa, les habría recomendado la lectura de la Resolución del Parlamento Europeo, de 2 de marzo de 2017, sobre las opciones de la Unión para mejorar el acceso a los medicamentos. Su valor jurídico es más bien limitado; pero se trata de... Read More